Budapest, January 17, 2008 – BD announced today that it is planning to build a state-of-the-art prefillable syringe manufacturing facility in Tatabánya, Hungary. The plant would be built on the site of the Tatabánya-KörnyeIndustrial Park, one of Hungary’s first and largest industrial park.
“We chose Hungary because of its proximity to the European markets these products will serve, as well as its pool of educated workers, the availability of qualified subcontractors, and an exceptional work ethic,” said Alexandre Conroy, President, BD Medical - Pharmaceutical Systems.
BD expects that this approximately 100M € expansion will create approximately 500 jobs over the next 6 years. The market for prefillable syringes continues to grow, and the new facility would be built to meet this growing demand.Jobs at the plant will vary from highly trained operations personnel to administrative and maintenance jobs.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.